Foot Locker Stock a...
Health Care: Health Services
Response Genetics Inc. (RGDX: NASDAQ)
$1.52 0.00 | 0.00%
06/19/13 - 01:35 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| RGDX | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 16.92 | 27.73 | -37.45 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -17.30 | 1.07 | 0.27 |
| Net Income | -0.17 | 0.00 | |
| EPS | -0.59 | 0.00 |
Earnings for RGDX:
| EBITDA | -7.00 |
| REVENUE | 18.74M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.05 | $-0.05 | $-0.19 | $-0.19 |
| Number of Analysts | 1 | 1 | 1 | 1 |
| High Estimate | $-0.05 | $-0.05 | $-0.19 | $-0.19 |
| Low Estimate | $-0.05 | $-0.05 | $-0.19 | $-0.19 |
| Prior Year | $-0.11 | $-0.05 | $-0.29 | $-0.19 |
| Growth Rate (Year over Year) | 54.55% | 0.00% | 34.48% | 0.00% |
Portfolios with RGDX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks With Big Insider Buy...
- Userjaysan Portfolio 1
- Usercurry Portfolio 1
- Usercharlesl950 Portfolio 1
- UserWACKJDDUDE Portfolio 1
Latest RGDX Headlines from TheStreet
- Response Genetics Achieves Milestone Payments Totaling $1,000,000 For Services Provided To GlaxoSmithKline In The Development Of BRAF-Inhibitor Tafinlar(R) (dabrafenib) 06.04.13 | 07:06 am
- Response Genetics, Inc. Announces Presentations At The American Society Of Clinical Oncology 2013 Annual Meeting 05.20.13 | 07:05 am
- Response Genetics, Inc. Announces Contract With Blue Shield Of California 05.16.13 | 07:05 am
- Response Genetics, Inc. Announces First Quarter 2013 Financial Results 05.14.13 | 07:05 am
- Response Genetics To Present At The 2013 UBS Global Healthcare Conference 05.08.13 | 07:05 am
- Response Genetics, Inc. To Release First Quarter 2013 Financial Results And Host Conference Call On May 14, 2013 05.06.13 | 07:05 am
- Response Genetics, Inc. Announces Fourth Quarter And Year-End 2012 Financial Results 03.21.13 | 07:03 am
- Response Genetics To Present At The 25th Annual ROTH Conference 03.12.13 | 07:03 am
- Response Genetics, Inc. To Release Fourth Quarter And Year-End 2012 Financial Results And Host Conference Call On March 21, 2013 03.07.13 | 07:03 am
- 5 Under-$10 Stocks Setting Up to Trade Higher 11.30.12 | 12:11 pm
Press Releases for RGDX
- Response Genetics, Inc. To Offer Enhanced ALK Testing Program For Metastatic Lung Cancer Patients - Business Wire 06.28.12 | 08:06 am
- Response Genetics Announces Presentation Of Lung Cancer Study Results At 2012 American Society Of Clinical Oncology Annual Meeting - Business Wire 05.30.12 | 08:05 am
- Response Genetics, Inc. Announces First Quarter Financial Results - Business Wire 05.10.12 | 08:05 am
- Response Genetics, Inc. To Release First Quarter Financial Results And Host Conference Call On May 10, 2012 - Business Wire 05.04.12 | 08:05 am
- Response Genetics, Inc. Announces Year-End And Fourth Quarter Financial Results - Business Wire 03.27.12 | 08:03 am
- Response Genetics, Inc. Announces Appointment Of Stephanie Astrow, Ph.D., As Vice President, Research And Development - Business Wire 03.26.12 | 08:03 am
- Response Genetics, Inc. To Release Fourth Quarter And Full-Year 2011 Financial Results And Host Conference Call On March 27, 2012 - Business Wire 03.21.12 | 08:03 am
- Response Genetics Regains NASDAQ Compliance - Business Wire 02.21.12 | 07:02 am
- Response Genetics To Present At The 22nd Annual UBS Global Healthcare Services Conference - Business Wire 02.06.12 | 07:02 am
- Response Genetics Raises More Than $7.8 Million In Financing - Business Wire 02.02.12 | 07:02 am
Partner Headlines for RGDX
- Benzinga's Small Cap Movers for Friday November 30, 2012 - Benzinga 12.02.12 | 11:12 am
- Glaxo Increases Stake in RGDX - Analyst Blog - NASDAQ 09.18.12 | 09:09 pm
- Response Genetics: This Train Is About To Leave The Station - Seeking Alpha 02.16.12 | 09:02 am
- Response Genetics Stock Soars 31% On $7.8M Offering News - Seeking Alpha 02.03.12 | 08:02 am
- Biomarker Diagnostics Drive Personalized Medicine but Path to Market Still Rife With Hurdles - Seeking Alpha 07.07.10 | 07:07 am
- Three Promising Small-Cap Cancer Plays - Seeking Alpha 05.17.10 | 08:05 am
- Response Genetics: An Earnings Primer - Seeking Alpha 05.12.10 | 06:05 am
- UPDATE 1-Response Genetics inks deal with Glaxo, shares soar - Reuters 05.11.10 | 10:05 am
